The Biden administration is currently evaluating whether to delay or alter proposed regulations that would effectively ban many hemp-derived products, such as those containing Delta-8 THC. These products have occupied a legal gray area since the 2018 Farm Bill, and the industry has faced increasing pressure from federal regulators seeking to tighten oversight.

Recent reporting has highlighted a potential conflict of interest regarding this policy shift. Bret Worley, the CEO of a global hemp product supplier, is the son-in-law of Susie Wiles, a prominent political strategist and incoming White House Chief of Staff. Worley married Wiles’ daughter, Caroline, in June of this year. Critics and transparency advocates argue that any administration action to protect or delay regulations on the hemp industry could be perceived as providing a financial advantage to a family member of a high-ranking official.

While the White House has not issued a formal statement confirming a specific delay, the intersection of the hemp industry's regulatory future and the personal connections of senior staff has drawn attention to the administration's ethics policies. The hemp industry maintains that these products are legal under current federal guidelines, while public health advocates argue that the lack of regulation poses risks to consumers. The administration has yet to clarify how it intends to balance these competing interests or whether it will implement recusal protocols regarding the hemp policy decision-making process.